Matthew Porteus
Plus aucun poste en cours
Fortune : 11 M $ au 31/03/2024
Postes actifs de Matthew Porteus
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Stanford School of Medicine | Corporate Officer/Principal | 01/10/2010 | - |
| Stanford University | Corporate Officer/Principal | - | - |
Historique de carrière de Matthew Porteus
Anciens postes connus de Matthew Porteus
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 01/02/2003 | 01/08/2010 |
| LENZ THERAPEUTICS, INC. | Director/Board Member | 01/03/2020 | - |
| Founder | 01/06/2017 | - | |
| CRISPR THERAPEUTICS AG | Founder | 31/10/2013 | - |
Formation de Matthew Porteus
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Suisse | 2 |
Opérationnelle
| Founder | 3 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Matthew Porteus
- Expérience
